Who Owns INMB?

INmune Bio, Inc. — Institutional Ownership & 13F Holdings

$1.42

+0.09 (+6.39%)

Market Cap

$39.1M

Shares Outstanding

26,585,258

Institutional Holders

80

Total Inst. Value

$43.0M

% of Float Held

28.8%

QoQ Holder Change

+36

Institutional data as of Q1 2025

New Positions

21

Closed Positions

9

Increased

23

Decreased

21

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1BlackRock, Inc.$7.4M948,362
2Praetorian PR LLC$6.8M865,000
3VANGUARD GROUP INC$6.5M826,613
4RAYMOND JAMES FINANCIAL INC$3.0M382,041
5GEODE CAPITAL MANAGEMENT, LLC$2.8M364,862
6STATE STREET CORP$1.8M236,128
7NORTHERN TRUST CORP$1.2M152,445
8UBS Group AG$1.1M137,315
9Dauntless Investment Group, LLC$1.0M130,680
10MAI Capital Management$834K106,797

Biggest Buyers & Sellers This Quarter

Top Buyers

Top Sellers

Related Stocks

Frequently Asked Questions

How many institutional investors hold INMB?

As of Q1 2025, 80 institutional investors report holding INMB (INmune Bio, Inc.) in their 13F filings.

What percentage of INmune Bio, Inc. is owned by institutions?

Institutional investors hold approximately 28.8% of INmune Bio, Inc.'s float as reported in SEC 13F filings.

Which hedge fund owns the most INMB?

The largest institutional holder of INMB is BlackRock, Inc. with $7.4M in shares.

Are institutions buying or selling INMB?

This quarter, 21 institutions opened new positions in INMB and 9 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.